Envoy Medical (COCH) Long-Term Investments (2021 - 2023)

Envoy Medical (COCH) has 3 years of Long-Term Investments data on file, last reported at $44.6 million in Q2 2023.

• For the quarter ending Q2 2023, Long-Term Investments fell 89.51% year-over-year to $44.6 million; the trailing twelve-month figure through Jun 2023 stood at $44.6 million (down 89.51% YoY), and the FY2022 full-year result was $430.0 million, up 1.18% from the prior year.
• Long-Term Investments climbed to $44.6 million in Q2 2023, from $44.4 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $430.0 million in Q4 2022 to a low of $44.4 million in Q1 2023.
• A 3-year average of $349.2 million and a median of $425.0 million in 2021 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments climbed 1.21% in 2022 and slumped 89.56% in 2023, its largest moves.
• Tracing COCH's Long-Term Investments over 3 years: stood at $425.0 million in 2021, then climbed by 1.18% to $430.0 million in 2022, then slumped by 89.62% to $44.6 million in 2023.
• Business Quant data shows COCH's Long-Term Investments at $44.6 million in Q2 2023, $44.4 million in Q1 2023, and $430.0 million in Q4 2022.